2022-06-30 22_26_08-Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therap Posted on June 30, 2022 Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD 1540 × 750